Related Experiment Video
Updated: Aug 19, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
[Mandibular advancement devices in the treatment of obstructive sleep apnea]
Piotr Korczyński1, Katarzyna Górska, Krzysztof Wilk
1Klinika Chorób Wewnetrznych Pneumonologii i Alergologii Akademii Medycznej w Warszawie. pkorczyn@amwaw.edu.pl
Unlabelled:
Obstructive sleep apnea (OSA) affects approximately 450,000 people in Poland. Use of nasal continuous positive airway pressure (nCPAP) devices and laryngeal surgery are widely accepted OSA treatment methods. In 1995 ASDA approved oral devices for treatment of OSA patients. The aim of the study was to determine efficiency of mandibular advancement devices (MAD) in OSA therapy.
Material And Methods:
The study group included 20 patients with OSA, all of whom did not tolerate nCPAP and did not have indications or did not agree for surgical treatment.
Results:
Control polysomnography was carried out in 11 patients using MAD. In 64% of patients AHI was lower then 10. No correlation between MAD use and AHI values was found. 45% of patients declared improvement of sleep quality and life comfort.
Conclusions:
Use of mandibular advancement devices is an important alternative therapy of OSA.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques